Yale Department of Internal Medicine clinicians, researchers, educators, staff, and trainees were awarded $1.36 million in grants in February 2025.
Prime PI | Project Title | Sponsor | Date | Spons Proj Budget |
---|---|---|---|---|
Chamie, Daniel | Cardiac CT Deblooming | National Institute of Neurological Disorders and Stroke/NIH/DHHS | 07/01/24 - 6/30/25 | $70,174 |
Festa, Natalia | Investigating Modifiable Determinants of Post-Disaster Outcomes for Rural Nursing Home Residents | Donaghue (Patrick and Catherine Weldon) Medical Research Foundation | 01/01/25 - 12/31/26 | $135,135 |
Fikrig, Erol | ATF: Novel Diagnostic Biomarker Discovery and Validation for Malaria | NIH/DHHS | 12/01/24 - 11/30/25 | $98,384 |
Gallegos Kattan, Cesia M | ATF: Yale- HIC Symposia CME Program | BridgeBio Pharma, Inc. | 01/17/25 - 6/30/25 | $10,000 |
Jane-Wit, Daniel D | Loss of Proteostasis and Vascular Amyloidosis | Department of the Army | 02/15/25 - 2/14/27 | $460,279 |
Jonas, Elizabeth A | Mitochondrial dysfunction as a mechanism to explain sleep dysregulation in bipolar disorder | BD² Breakthrough Discoveries for thriving with Bipolar Disorder | 09/01/24 - 8/31/25 | $50,000 |
Kumar, Priti | Modulation of Galectin-9 to Target HIV Persistence | National Institute of Allergy and Infectious Diseases/NIH/DHHS | 08/01/24 - 6/30/25 | $224,981 |
Lansky, Alexandra J | Self-Expanding Coronary Sinus Reducer for Treating Symptomatic Coronary Artery Disease (SERRA-I study) | VahatiCor, Inc | 02/19/25 - 2/18/30 | $276,569 |
Miller, Edward J | Yale-HIC Cardiac Amylodosis Symposia | AstraZeneca Pharmaceutical LP | 06/01/24 - 5/31/25 | $34,524 |